Search results

• Gentamicin
  ...erial infections (because of the risk of the patient going into shock from lipid A [[endotoxin]] found in certain Gram-negative organisms). ...ometimes causing complete hearing loss<ref>http://www.american-hearing.org/disorders/bilat/gentamicin_toxicity.html Gentamicin Toxicity] at the American Hearing
  9 KB (1,199 words) - 16:43, 27 September 2010
• Cycloserine
  The terminal two amino acid residues of the [[murein]] precursor [[lipid II]] consist of [[D-alanine]], which is produced by the enzyme [[alanine ra ...also being trialed as an [[adjuvant]] to [[exposure therapy]] for anxiety disorders (e.g. [[phobias]]<ref name="Davis">{{cite journal |last=Davis |first=Michae
  5 KB (602 words) - 16:44, 27 September 2010
• Metformin
  ...that could increase the risk of [[lactic acidosis]], including [[kidney]] disorders ([[creatinine]] levels over 150 μmol/l,<ref name="Jones2003">{{vcite journ ...signaling, whole body energy balance, and the metabolism of glucose and [[lipid|fat]]s;<ref>{{vcite journal |author=Towler MC, Hardie DG |title=AMP-activat
  66 KB (8,976 words) - 16:47, 27 September 2010
• List of World Health Organization Essential Medicines
  ...s, medicines used to treat gout and disease modifying agents in rheumatoid disorders== ===Disease modifying agents used in rheumatoid disorders (DMARDs)===
  16 KB (1,353 words) - 21:21, 3 October 2011
• Salbutamol
  ...aak MA |title=beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men |journal=J. Clin. Endocrinol. Metab. |vol ...lock sodium channels predicts their therapeutic use in muscle excitability disorders |journal=Mol. Pharmacol. |volume=63 |issue=3 |pages=659–70 |year=2003 |mo
  15 KB (2,005 words) - 16:49, 27 September 2010
• Morphine
  ...an morphine on a milligram-for-milligram basis. Due to the [[lipophilicity|lipid solubility]] of diacetylmorphine, it is able to cross the [[blood-brain bar ...{Citation needed|date=January 2009}} In the presence of pain and the other disorders for which morphine is indicated, a combination of psychological and physiol
  87 KB (12,376 words) - 16:51, 27 September 2010
• Diazepam
  ...y weight and condition being treated. For the elderly or people with liver disorders, initial dose is at the low end of the range, with the dose being increased * Liver disorders
  78 KB (10,295 words) - 16:51, 27 September 2010
• Depleted uranium
  ...m and long-term depleted uranium exposure on open-field behavior and brain lipid oxidation in rats. Increased rates of [[immune system]] disorders and other wide-ranging symptoms, including chronic pain, fatigue and memory
  80 KB (11,721 words) - 10:13, 20 September 2010
• Lanolin
  .... Lanolin alcohols are a rich source of [[cholesterol]] (an important skin lipid) and are powerful water-in-oil emulsifiers; they have been used extensively ...ty grades of lanolin are ideally suited to the treatment of dermatological disorders such as [[eczema]] and on open wounds.<ref>MR Arden Jones, I Steel and SM P
  14 KB (2,180 words) - 10:17, 20 September 2010
• Carbon monoxide poisoning
  ...diac output]], [[anemia]], [[sickle cell disease]] and other hematological disorders, [[barometric pressure]], and [[metabolic rate]].<ref>{{cite web|url=http:/ ...hondrial]] [[cytochrome oxidase]], and carbon monoxide causing [[brain]] [[lipid peroxidation]].<ref name="Weaver-NEJM"/><ref name="Toxicology2003-Gorman"/>
  71 KB (9,723 words) - 21:31, 20 September 2010
• Lead poisoning
  ...causing potentially permanent [[learning disorder|learning]] and behavior disorders. Symptoms include abdominal pain, headache, [[anemia]], irritability, and ...organic lead, which is probably more toxic than inorganic lead due to its lipid solubility, occur rapidly.<ref name="Timbrell08">{{cite book |author = |tit
  90 KB (13,109 words) - 21:36, 20 September 2010
• List of cutaneous conditions
  [[Autoinflammatory syndromes]] are a group of inherited disorders characterized by bouts of [[inflammation|inflammatory]] [[skin lesion]]s an ...ref><ref>{{cite journal |author=Eming R, Hertl M |title=Autoimmune bullous disorders |journal=Clin Chem Lab Med |volume=44 |issue=2 |pages=144–9 |year=2006 |p
  177 KB (19,269 words) - 21:05, 21 September 2010
• List of diseases (L)
  * [[Lipid storage myopathy]] * [[Lysosomal disorders]]
  9 KB (838 words) - 21:07, 21 September 2010
• Phosphate homeostasis
  .../ref><ref>{{cite journal | author=Nishizuka Y | title=Protein kinase C and lipid signaling for sustained cellular responses | journal=FASEB J| year=1995 | v Two rare autosomal recessive metabolic disorders characterized by hyperphosphatemia: [[Calcinosis#Tumoral calcinosis|hyperph
  63 KB (9,050 words) - 21:26, 21 September 2010
• Hematopoietic stem cell transplantation
  ** [[Phagocyte disorders]] ** [[Myeloproliferative disorders]]
  41 KB (5,684 words) - 21:26, 21 September 2010
• Cannabinoid
  Phytocannabinoids are nearly insoluble in water but are soluble in [[lipid]]s, [[alcohol]]s, and other non-polar [[organic solvent]]s. However, as [[p ...rotenhermen F. "Cannabinoids." ''Current Drug Targets - CNS & Neurological Disorders''. 2005 Oct;4(5):507-30. PMID 16266285</ref> It is found in nearly all tiss
  49 KB (6,487 words) - 22:06, 21 September 2010
• Neuroproteomics
  ...unique in that they do not always exhibit outward symptoms. Defining the disorders becomes difficult and so neuroproteomics is a step in the right direction o ...proach dedicated to studying proteomic changes in the field of psychiatric disorders, particularly substance-and drug-abuse neurotoxicity.
  17 KB (2,530 words) - 22:11, 21 September 2010
• Amyloid precursor protein
  ...ntalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts | journal = Curr. Biol. | volume = 11 | issue = 16 | pages = 1288–9 ...t APP interacts with [[reelin]], a protein implicated in a number of brain disorders, including Alzheimer's disease.<ref name="pmid19515914">{{cite journal | au
  36 KB (4,595 words) - 22:11, 21 September 2010
• Low-affinity nerve growth factor receptor
  ...e therapeutic treatment of Parkinson's disease |journal=CNS & Neurological Disorders Drug Targets |volume=7 |issue=6 |pages=512–23 |year=2008 |month=December ...itle=PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts |journal=EMBO J. |volume=22 |issue=8 |pages=1790–800 |publisher= |l
  13 KB (1,750 words) - 22:12, 21 September 2010
• Ion channel
  ...y packed around a water-filled pore through the plane of the membrane or [[lipid bilayer]].<ref name="isbn0-87893-741-2">{{cite book | author = Purves,| aut ...of ion channels and have disastrous consequences for the organism. Genetic disorders of ion channels and their modifiers are known as [[Channelopathy|Channelopa
  31 KB (4,177 words) - 22:12, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)